Worldwide Insulin (Medication) Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026
- PRO4426705
- 122 Pages
- May 2021
- Pharmaceuticals
Geographically, the global Insulin (Medication) market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Insulin (Medication) market in North America.
Significant participants active in the global Insulin (Medication) market include: USV Limited (India), Eli Lilly and Company (U.S.), Wockhardt Ltd.( India), Piramal Healthcare (India), Biocon Ltd. (India), Sanofi (France), Bioton (Poland), Biodel Inc. (U.S.), Ganlee (China), Dongbao Enterprise Group Co. (China), Wanbang Biopharma Co. (China), Novo Nordisk (Denmark), Julphar (U.A.E.)...
Global Insulin (Medication) Market Segmentation:
Insulin (Medication) market, by Insulin (Medication) type:
Long-Acting Insulin and Sales Growth Rate 2011-2020
Rapid-Acting Insulin and Sales Growth Rate 2011-2020
Intermediate-Acting Insulin and Sales Growth Rate 2011-2020
Premixed Insulin and Sales Growth Rate 2011-2020
…
Insulin (Medication) market, by Application:
Type 1 Diabetes mellitus
Type 2 Diabetes mellitus
…
Insulin (Medication) Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Insulin (Medication) by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Insulin (Medication) Market-Segmentation
4.1 By Type
4.1.1 Long-Acting Insulin and Sales Growth Rate 2011-2020
4.1.2 Rapid-Acting Insulin and Sales Growth Rate 2011-2020
4.1.3 Intermediate-Acting Insulin and Sales Growth Rate 2011-2020
4.1.4 Premixed Insulin and Sales Growth Rate 2011-2020
4.2 By End-User/Application Industry
4.2.1 Type 1 Diabetes mellitus
4.2.2 Type 2 Diabetes mellitus
4.3 By Geography
4.3.1 North America Insulin (Medication) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Insulin (Medication) Production from 2014-2020
4.3.1.2 North America Insulin (Medication) Consumption from 2014-2020
4.3.1.3 North America Insulin (Medication) Import and Export from 2014-2020
4.3.1.4 North America Insulin (Medication) Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Insulin (Medication) Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Insulin (Medication) Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Insulin (Medication) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Insulin (Medication) Production from 2014-2020
4.3.2.2 Europe Insulin (Medication) Consumption from 2014-2020
4.3.2.3 Europe Insulin (Medication) Import and Export from 2014-2020
4.3.2.4 Europe Insulin (Medication) Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Insulin (Medication) Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Insulin (Medication) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Insulin (Medication) Production from 2014-2020
4.3.3.2 Asia-Pacific Insulin (Medication) Consumption from 2014-2020
4.3.3.3 Asia-Pacific Insulin (Medication) Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Insulin (Medication) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Insulin (Medication) Production from 2014-2020
4.3.4.2 Latin America Insulin (Medication) Consumption from 2014-2020
4.3.4.3 Latin America Insulin (Medication) Import and Export from 2014-2020
4.3.4.4 Latin America Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Insulin (Medication) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Insulin (Medication) Production from 2014-2020
4.3.5.2 Middle East & Africa Insulin (Medication) Consumption from 2014-2020
4.3.5.3 Middle East & Africa Insulin (Medication) Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 USV Limited (India)
5.1.1 USV Limited (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 USV Limited (India) Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Eli Lilly and Company (U.S.)
5.2.1 Eli Lilly and Company (U.S.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Eli Lilly and Company (U.S.) Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Wockhardt Ltd.( India)
5.3.1 Wockhardt Ltd.( India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Wockhardt Ltd.( India) Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Piramal Healthcare (India)
5.4.1 Piramal Healthcare (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Piramal Healthcare (India) Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Biocon Ltd. (India)
5.5.1 Biocon Ltd. (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Biocon Ltd. (India) Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Sanofi (France)
5.6.1 Sanofi (France) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Sanofi (France) Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Bioton (Poland)
5.7.1 Bioton (Poland) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Bioton (Poland) Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Biodel Inc. (U.S.)
5.8.1 Biodel Inc. (U.S.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Biodel Inc. (U.S.) Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Ganlee (China)
5.9.1 Ganlee (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Ganlee (China) Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Dongbao Enterprise Group Co. (China)
5.10.1 Dongbao Enterprise Group Co. (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Dongbao Enterprise Group Co. (China) Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Wanbang Biopharma Co. (China)
5.11.1 Wanbang Biopharma Co. (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Wanbang Biopharma Co. (China) Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Novo Nordisk (Denmark)
5.12.1 Novo Nordisk (Denmark) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Novo Nordisk (Denmark) Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Julphar (U.A.E.)
5.13.1 Julphar (U.A.E.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Julphar (U.A.E.) Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Insulin (Medication) Market from 2021-2026
7.1 Future Forecast of Global Insulin (Medication) Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Insulin (Medication) Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Insulin (Medication) Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Insulin (Medication) Market Value ($) and Growth Rate of Insulin (Medication) from 2014-2026
Global Insulin (Medication) Production and Growth Rate Segment by Product Types from 2014-2026F
Global Insulin (Medication) Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Insulin (Medication) Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Insulin (Medication) Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Long-Acting Insulin and Sales Growth Rate 2011-2020 of Insulin (Medication)
Figure Rapid-Acting Insulin and Sales Growth Rate 2011-2020 of Insulin (Medication)
Figure Intermediate-Acting Insulin and Sales Growth Rate 2011-2020 of Insulin (Medication)
Figure Premixed Insulin and Sales Growth Rate 2011-2020 of Insulin (Medication)
Table Global Insulin (Medication) Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Insulin (Medication) Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Type 1 Diabetes mellitus of Insulin (Medication)
Figure Type 2 Diabetes mellitus of Insulin (Medication)
Table Global Insulin (Medication) Production Value ($) by Regions
Table Global Insulin (Medication) Production Value Share by Regions
Table Global Insulin (Medication) Production by Regions
Table Global Insulin (Medication) Production Share by Regions
Table Global Insulin (Medication) Consumption by Regions
Table Global Insulin (Medication) Consumption Share by Regions
Figure North America Insulin (Medication) Production and Growth Rate from 2014-2020
Figure North America Insulin (Medication) Consumption and Growth Rate from 2014-2020
Table North America Insulin (Medication) Import and Export from 2014-2020
Table North America Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
Table North America Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
Table North America Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
Figure Europe Insulin (Medication) Production and Growth Rate from 2014-2020
Figure Europe Insulin (Medication) Consumption and Growth Rate from 2014-2020
Table Europe Insulin (Medication) Import and Export from 2014-2020
Table Europe Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
Table Europe Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
Table Europe Insulin (Medication) Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Insulin (Medication) Production and Growth Rate from 2014-2020
Figure Asia-Pacific Insulin (Medication) Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Insulin (Medication) Import and Export from 2014-2020
Table Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
Figure Latin America Insulin (Medication) Production and Growth Rate from 2014-2020
Figure Latin America Insulin (Medication) Consumption and Growth Rate from 2014-2020
Table Latin America Insulin (Medication) Import and Export from 2014-2020
Table Latin America Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Insulin (Medication) Production and Growth Rate from 2014-2020
Figure Middle East & Africa Insulin (Medication) Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Insulin (Medication) Import and Export from 2014-2020
Table Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Insulin (Medication) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Insulin (Medication) Participants Value ($) and Market Share (%) in 2019
Table USV Limited (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure USV Limited (India) Sales and Growth Rate from 2014-2020
Figure USV Limited (India) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Eli Lilly and Company (U.S.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Eli Lilly and Company (U.S.) Sales and Growth Rate from 2014-2020
Figure Eli Lilly and Company (U.S.) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Wockhardt Ltd.( India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Wockhardt Ltd.( India) Sales and Growth Rate from 2014-2020
Figure Wockhardt Ltd.( India) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Piramal Healthcare (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Piramal Healthcare (India) Sales and Growth Rate from 2014-2020
Figure Piramal Healthcare (India) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biocon Ltd. (India) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biocon Ltd. (India) Sales and Growth Rate from 2014-2020
Figure Biocon Ltd. (India) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Sanofi (France) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Sanofi (France) Sales and Growth Rate from 2014-2020
Figure Sanofi (France) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Bioton (Poland) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Bioton (Poland) Sales and Growth Rate from 2014-2020
Figure Bioton (Poland) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biodel Inc. (U.S.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biodel Inc. (U.S.) Sales and Growth Rate from 2014-2020
Figure Biodel Inc. (U.S.) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Ganlee (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Ganlee (China) Sales and Growth Rate from 2014-2020
Figure Ganlee (China) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Dongbao Enterprise Group Co. (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Dongbao Enterprise Group Co. (China) Sales and Growth Rate from 2014-2020
Figure Dongbao Enterprise Group Co. (China) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Wanbang Biopharma Co. (China) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Wanbang Biopharma Co. (China) Sales and Growth Rate from 2014-2020
Figure Wanbang Biopharma Co. (China) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Novo Nordisk (Denmark) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Novo Nordisk (Denmark) Sales and Growth Rate from 2014-2020
Figure Novo Nordisk (Denmark) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Julphar (U.A.E.) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Julphar (U.A.E.) Sales and Growth Rate from 2014-2020
Figure Julphar (U.A.E.) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Insulin (Medication) Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Insulin (Medication) Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Insulin (Medication) Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Insulin (Medication) Production and Growth Rate Forecast by Types (2021-2026)
Table Global Insulin (Medication) Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
